Subscribe To
MGTA / Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%
MGTA News
By Pulse2
February 5, 2023
MGTA Stock: 51.66% Surge Explained
The stock price of Magenta Therapeutics Inc (NASDAQ: MGTA) surged by 51.66% in the most recent trading session. This is why. more_horizontal
By Zacks Investment Research
December 21, 2022
Magenta (MGTA) Down on Pipeline Update for Leukemia Drug
Magenta Therapeutics (MGTA) stops dosing participants in a phase I/II study cohort, evaluating its blood cancer pipeline candidate due to dose-limitin more_horizontal
By Pulse2
December 20, 2022
Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%
The stock price of Magenta Therapeutics (MGTA) plummeted over 50% intraday today. This is why. more_horizontal
By Zacks Investment Research
May 16, 2022
After Plunging 49.1% in 4 Weeks, Here's Why the Trend Might Reverse for Magenta Therapeutics, Inc. (MGTA)
The heavy selling pressure might have exhausted for Magenta Therapeutics, Inc. (MGTA) as it is technically in oversold territory now. In addition to t more_horizontal